# IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy

> **NCT06462144** · EARLY_PHASE1 · TERMINATED · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 3 (actual)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)
- ANCA Associated Vasculitis (AAV)
- Idiopathic Inflammatory Myopathy (IIM)

## Interventions

- **DRUG:** IMPT-514 CART Cell Injection

## Key facts

- **NCT ID:** NCT06462144
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-06-13
- **Primary completion:** 2025-10-21
- **Final completion:** 2025-10-21
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** The collaborating party has adjusted its R\&D strategy and terminated the study.
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06462144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06462144, "IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06462144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*